SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently trending as shareholders react to the official approval of a 1-for-12 reverse stock split, sparking intense debate over whether this move is a necessary structural correction or a sign of deeper financial distress. While some investors are expressing frustration over stagnant performance and leadership concerns, others are actively tracking heavy call option activity and speculating that the reduced float could set the stage for a potential short squeeze.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is currently seeing intense investor scrutiny and volatility as the community remains deeply divided over the company's financial stability, impending trial readouts, and the performance of current leadership. Investors are actively debating the potential for a Phase 3 SENTRY trial success versus the significant risks posed by high debt levels and the necessity for strategic financing to extend operations.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing a surge in trading volume and investor interest following unconfirmed market rumors regarding potential M&A activity. Community members are actively debating the credibility of these reports while comparing the stock's current valuation and pipeline potential to past biotech acquisition trends.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as traders debate its potential as a low-cap meme coin while community members highlight extreme volatility, aggressive pump-and-dump warnings, and widespread skepticism regarding its long-term viability.

Hesai Group engages in the development, manufacture and sale of three-dimensional light detection and ranging(lidar) solutions. The company’s lidar products enable a broad spectrum of applications across passenger and commercial vehicles with advanced driver assistance systems (ADAS) and autonomous vehicle fleets. The company was founded by Yi Fan Li, Kai Sun, and Shao Qing Xiang in October 2014 and is headquartered in Shanghai, China.

Hesai Group - ADR

Hesai Group is trending following strong guidance for lidar shipments and revenue, alongside a strategic partnership with NVIDIA's AI inspection lab that strengthens its positioning in the autonomous and robotics sectors. While some investors are bullish on the company's market-leading growth and design wins with major OEMs, others are actively debating potential risks related to geopolitical tensions, audit transparency, and competitive threats in the lidar space.

Concentrix Corp. engages in the provision of customer experience solutions and technology. The company was founded in 1973 and is headquartered in Newark, CA.

Concentrix Corp.

Concentrix Corporation

Concentrix is seeing intense investor focus as the stock reacts to mixed Q1 results and the announced $4.8 billion merger with Webhelp. While the community is actively debating the implications of the deal on long-term growth and debt levels, traders are closely tracking the stock's volatility and its potential to capture synergy-driven value.

Smithfield Foods, Inc. operates as a meat-processing company. The firm processes and produces pork and hog. Its brands include Smithfield, Eckrich, Nathan's Famous, Farmland, and Armour. The company was founded by Joseph Williamson Luter, Sr. and Joseph Williamson Luter, Jr. in 1936 and is headquartered in Smithfield, VA.

Smithfield Foods, Inc.

Smithfield Foods Inc.

Smithfield Foods is trending as investors digest a strong quarterly earnings report that exceeded consensus estimates for both revenue and EPS. Market participants are actively discussing the company's dividend increase, strategic expansion through the acquisition of the Nathans Famous brand, and the impact of evolving USDA rules on meat processing operations.

Core & Main, Inc. is a specialty distributor focused on water, wastewater, storm drainage and fire protection products, and related services. The company provides infrastructure solutions to municipalities, private water companies and professional contractors across municipal, non-residential, and residential end markets, nationwide. The company was founded in 1874 and is headquartered in St. Louis, MO.

Core & Main Inc - Ordinary Shares Class A

Core & Main Inc

Core & Main is seeing active engagement as investors digest the company's latest quarterly earnings, which showed solid sales growth and raised full-year guidance despite broader macroeconomic headwinds. The community is focused on the firm's acquisition-heavy growth strategy and its role as a key player in U.S. water infrastructure, with many debating the impact of ongoing share repurchases on long-term value.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is under intense scrutiny after announcing a $1B share repurchase program, sparking polarized debate among investors regarding its long-term viability versus rivals like NIO. Community sentiment is deeply divided, with some betting on a rebound supported by the buyback and potential technological pivots, while vocal critics point to shifting delivery momentum, margin pressures, and intense competition from peers as reasons to divest.

Paycom Software, Inc. engages in the provision of cloud-based human capital management software solutions delivered as software-as-a-service. It offers functionality and data analytics that businesses need to manage the complete employment life cycle from recruitment to retirement. The company was founded by Chad R. Richison in 1998 and is headquartered in Oklahoma City, OK.

Paycom Software Inc

Paycom Software (PAYC) is facing heightened volatility and intense community debate as investors react to a challenging leadership landscape, ongoing insider selling, and significant growth deceleration. While some traders are attempting to bottom-fish the stock based on its strong balance sheet and automation potential, many others are expressing deep frustration over the company's corporate culture and disappointing performance guidance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Regulatory Wins, Capital Flows, and Global Expansion Drive Market Momentum

A wave of regulatory clarity, strategic financing, and global expansion is reshaping pockets of the market, with companies across biotech, mobility, and emerging healthcare infrastructure positioning for outsized growth. $MGRX, $TOVX, $ZYBT, $FFAI, $TGNT

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Large Decline in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT - Get Free Report) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling...

Zhengye Biotechnology (NASDAQ:ZYBT) Trading Up 2.8% - What's Next?

Zhengye Biotechnology (NASDAQ:ZYBT) Stock Price Up 2.8% - Should You Buy...

Zhengye Biotechnology Holding Ltd. engages in the manufacture and sale of veterinary vaccines. It offers a range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company was founded on March 24, 2023 and is headquartered in Jilin City, China.

Current Price	$1.00
Prev Close	$0.71
Open	$0.8873
Dividend Yield	N/A
50-Day Moving Average	$0.9237
Beta	1.57
Avg. Volume	19,153.11
PE Ratio	-17.76

52-Week High	$14.30
52-Week Low	$0.68
Market Capitalization	$47.39M
EPS (Annual)	$0.0333
Price to Book	1.14
Revenue Per Employee	$93,480.95

ZYBT
Zhengye Biotechnology Holding Ltd

Feed

News

Sentiment

Fundamentals

Info

Latest ZYBT News

ZYBTZhengye Biotechnology Holding Ltd